Mass. Biotech Co. Hit With Stock Drop Suit Over New Drug
By Katryna Perera ( July 31, 2023, 9:02 PM EDT) -- Massachusetts-based biotechnology company Aldeyra Therapeutics Inc. was hit with a proposed class action Monday by investors who claim the company and its top executives made false and misleading statements about a cancer treatment in development, causing damage to investors when the drug's revealed ineffectiveness tanked Aldeyra's stock price....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.